Press Releases

Jun 10, 2020

PharmaCyte Biotech Successfully Develops “Change History” for its Clinical Trial Product for Pancreatic Cancer

Jun 8, 2020

PharmaCyte Biotech Completes Final cGMP Audit of Manufacturing Facility for Pancreatic Cancer Clinical Trial Product

May 26, 2020

PharmaCyte Biotech Announces Final Major Study for IND Submission Has Begun

May 11, 2020

PharmaCyte Biotech Conducting Final Audit of Manufacturing Facility after Batch Records Deemed cGMP Compliant

May 6, 2020

PharmaCyte Biotech Receives Medical Devices Registration and Submits Pre-EUA Application to the FDA for COVID-19 Diagnostic Kit

May 4, 2020

PharmaCyte Biotech Completes Medical Manual for IND Filing

Apr 27, 2020

PharmaCyte Biotech Successfully Completes Pyrogenicity Testing

Apr 8, 2020

PharmaCyte Biotech Enters into License Agreement for COVID-19 Diagnostic Kits

Mar 12, 2020

PharmaCyte Biotech Addresses Submission of IND and Recent FDA-Required Testing

Feb 12, 2020

PharmaCyte Biotech Receives Certificates of Analysis and Batch Records for its Clinical Trial Product in Pancreatic Cancer